Characterization of biofilm growth and biocide susceptibility testing of Mycobacterium phlei using the MBEC™ assay system

被引:17
作者
Bardouniotis, E
Huddleston, W
Ceri, H
Olson, ME
机构
[1] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Biofilm Res Grp, Calgary, AB T2N 1N4, Canada
[3] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada
关键词
biofilm; MBEC (TM) assay; non-tuberculosis mycobacterium; biocide susceptibility; Mycobacterium phlei;
D O I
10.1111/j.1574-6968.2001.tb10851.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The importance of non-tuberculosis mycobacterial biofilm species in medicine, industry and the environment has recently gained attention. Our objectives were to characterize biofilm growth of Mycobacterium phlei M4, as a model of rapidly growing mycobacteria using the minimal biofilm eradication concentration (MBEC (TM)) and to compare biocide susceptibility of planktonic and biofilm organisms. Scanning electron microscopy was also carried out to observe biofilm morphology, With the exception of Sporicidin (R) and Virkon (R) the minimum bactericidal concentration values for all biocides tested were lower than the MBEC values. The MBECT (TM) assay system was seen to produce multiple and reproducible biofilms of M. phlei and to be a useful tool for susceptibility studies. (C) 2001 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 17 条
[1]   INFECTIONS WITH MYCOBACTERIUM-CHELONEI IN PATIENTS RECEIVING DIALYSIS AND USING PROCESSED HEMODIALYZERS [J].
BOLAN, G ;
REINGOLD, AL ;
CARSON, LA ;
SILCOX, VA ;
WOODLEY, CL ;
HAYES, PS ;
HIGHTOWER, AW ;
MCFARLAND, L ;
BROWN, JW ;
PETERSEN, NJ ;
FAVERO, MS ;
GOOD, RC ;
BROOME, CV .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (05) :1013-1019
[2]   Biofilms invade nephrology: Effects in hemodialysis [J].
Cappelli, G ;
Ballestri, M ;
Perrone, S ;
Ciuffreda, A ;
Inguaggiato, P ;
Albertazzi, A .
BLOOD PURIFICATION, 2000, 18 (03) :224-230
[3]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[4]   Introduction to biofilm [J].
Costerton, JW .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 11 (3-4) :217-221
[5]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[6]  
Cox R, 1997, INFECT CONT HOSP EP, V18, P136
[7]   Emergence of a unique group of necrotizing mycobacterial diseases [J].
Dobos, KM ;
Quinn, FD ;
Ashford, DA ;
Horsburgh, CR ;
King, CH .
EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :367-378
[8]   Epidemiology of infection by nontuberculous mycobacteria [J].
Falkinham, JO .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :177-+
[9]   Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum [J].
Hall-Stoodley, L ;
Lappin-Scott, H .
FEMS MICROBIOLOGY LETTERS, 1998, 168 (01) :77-84
[10]   Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions [J].
Hall-Stoodley, L ;
Keevil, CW ;
Lappin-Scott, HM .
JOURNAL OF APPLIED MICROBIOLOGY, 1999, 85 :60S-69S